{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:10:42Z","timestamp":1793718642070,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12015-022-10353-9","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T16:02:26Z","timestamp":1646928146000},"page":"2444-2457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease Via Tr1 Cells"],"prefix":"10.1007","volume":"18","author":[{"given":"Lingli","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-4225","authenticated-orcid":false,"given":"Jingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"issue":"7152","key":"10353_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier, R. J., & Podolsky, D. K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature., 448(7152), 427\u2013434. https:\/\/doi.org\/10.1038\/nature06005","journal-title":"Nature."},{"key":"10353_CR2","doi-asserted-by":"publisher","unstructured":"Zhao, M., Gonczi, L., Lakatos, P. L., & Burisch, J. (2021). The burden of inflammatory bowel disease in Europe in 2020. Journal of Crohn's & Colitis. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab029","DOI":"10.1093\/ecco-jcc\/jjab029"},{"issue":"18","key":"10353_CR3","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1042\/CS20171110","volume":"132","author":"KG Harris","year":"2018","unstructured":"Harris, K. G., & Chang, E. B. (2018). The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: New insights into complex disease. Clinical Science (London, England), 132(18), 2013\u20132028. https:\/\/doi.org\/10.1042\/CS20171110","journal-title":"Clinical Science (London, England)"},{"issue":"10","key":"10353_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/microorganisms7100440","volume":"7","author":"B Yue","year":"2019","unstructured":"Yue, B., Luo, X., Yu, Z., Mani, S., Wang, Z., & Dou, W. (2019). Inflammatory bowel disease: A potential result from the collusion between gut microbiota and mucosal immune system. Microorganisms., 7(10), 440. https:\/\/doi.org\/10.3390\/microorganisms7100440","journal-title":"Microorganisms."},{"issue":"10114","key":"10353_CR5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/s0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., et al. (2017). Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. The Lancet., 390(10114), 2769\u20132778. https:\/\/doi.org\/10.1016\/s0140-6736(17)32448-0","journal-title":"The Lancet."},{"issue":"12","key":"10353_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan, G. G. (2015). The global burden of IBD: From 2015 to 2025. Nature Reviews. Gastroenterology & Hepatology, 12(12), 720\u2013727. https:\/\/doi.org\/10.1038\/nrgastro.2015.150","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"4","key":"10353_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy., 8(4), 315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy."},{"issue":"17","key":"10353_CR8","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019). Biological functions of mesenchymal stem cells and clinical implications. Cellular and Molecular Life Sciences, 76(17), 3323\u20133348. https:\/\/doi.org\/10.1007\/s00018-019-03125-1","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10353_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fimmu.2015.00560","volume":"6","author":"P Mattar","year":"2015","unstructured":"Mattar, P., & Bieback, K. (2015). Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Frontiers in Immunology, 6, 560. https:\/\/doi.org\/10.3389\/fimmu.2015.00560","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10353_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., et al. (2018). Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews. Nephrology, 14(8), 493\u2013507. https:\/\/doi.org\/10.1038\/s41581-018-0023-5","journal-title":"Nature Reviews. Nephrology"},{"issue":"1","key":"10353_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13287-018-0991-1","volume":"9","author":"M Khosravi","year":"2018","unstructured":"Khosravi, M., Bidmeshkipour, A., Cohen, J. L., Moravej, A., Hojjat-Assari, S., Naserian, S., et al. (2018). Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation. Stem Cell Research & Therapy, 9(1), 273. https:\/\/doi.org\/10.1186\/s13287-018-0991-1","journal-title":"Stem Cell Research & Therapy"},{"issue":"16","key":"10353_CR12","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.7150\/thno.32260","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen, X., Cai, C., Xu, D., Liu, Q., Zheng, S., Liu, L., et al. (2019). Human mesenchymal stem cell-treated regulatory CD23+CD43+ B cells alleviate intestinal inflammation. Theranostics., 9(16), 4633\u20134647. https:\/\/doi.org\/10.7150\/thno.32260","journal-title":"Theranostics."},{"issue":"10","key":"10353_CR13","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/jcp.29601","volume":"235","author":"M Shahir","year":"2020","unstructured":"Shahir, M., Mahmoud Hashemi, S., Asadirad, A., Varahram, M., Kazempour-Dizaji, M., Folkerts, G., et al. (2020). Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells. Journal of Cellular Physiology, 235(10), 7043\u20137055. https:\/\/doi.org\/10.1002\/jcp.29601","journal-title":"Journal of Cellular Physiology"},{"key":"10353_CR14","doi-asserted-by":"publisher","unstructured":"Rabani, R., Volchuk, A., Jerkic, M., Ormesher, L., Garces-Ramirez, L., Canton, J., et al. (2018). Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis. The European Respiratory Journal, 51(4). https:\/\/doi.org\/10.1183\/13993003.02021-2017","DOI":"10.1183\/13993003.02021-2017"},{"issue":"1","key":"10353_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/cyto.a.23239","volume":"93","author":"C Uder","year":"2018","unstructured":"Uder, C., Bruckner, S., Winkler, S., Tautenhahn, H. M., & Christ, B. (2018). Mammalian MSC from selected species: Features and applications. Cytometry. Part A, 93(1), 32\u201349. https:\/\/doi.org\/10.1002\/cyto.a.23239","journal-title":"Cytometry. Part A"},{"issue":"2","key":"10353_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/apt.13864","volume":"45","author":"C Gregoire","year":"2017","unstructured":"Gregoire, C., Lechanteur, C., Briquet, A., Baudoux, E., Baron, F., Louis, E., et al. (2017). Review article: Mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics, 45(2), 205\u2013221. https:\/\/doi.org\/10.1111\/apt.13864","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10353_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biom11010082","volume":"11","author":"JZ Ko","year":"2021","unstructured":"Ko, J. Z., Johnson, S., & Dave, M. (2021). Efficacy and safety of mesenchymal stem\/stromal cell therapy for inflammatory bowel diseases:An up-to-date systematic review. Biomolecules., 11(1), 82. https:\/\/doi.org\/10.3390\/biom11010082","journal-title":"Biomolecules."},{"issue":"6","key":"10353_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2019.09.002","volume":"157","author":"L Cook","year":"2019","unstructured":"Cook, L., Stahl, M., Han, X., Nazli, A., MacDonald, K. N., Wong, M. Q., et al. (2019). Suppressive and gut-reparative functions of human type 1 T regulatory cells. Gastroenterology., 157(6), 1584\u20131598. https:\/\/doi.org\/10.1053\/j.gastro.2019.09.002","journal-title":"Gastroenterology."},{"key":"10353_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/3-540-27702-1_14","volume":"293","author":"MK Levings","year":"2005","unstructured":"Levings, M. K., & Roncarolo, M. G. (2005). Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells. Current Topics in Microbiology and Immunology, 293, 303\u2013326. https:\/\/doi.org\/10.1007\/3-540-27702-1_14","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"6652","key":"10353_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., et al. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature., 389(6652), 737\u2013742. https:\/\/doi.org\/10.1038\/39614","journal-title":"Nature."},{"issue":"7559","key":"10353_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani, N., Amezcua Vesely, M. C., Iseppon, A., Brockmann, L., Xu, H., Palm, N. W., et al. (2015). Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature., 523(7559), 221\u2013225. https:\/\/doi.org\/10.1038\/nature14452","journal-title":"Nature."},{"issue":"7591","key":"10353_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X., Blanco, J., Ambalavanan, P., Yamanouchi, J., Singha, S., Fandos, C., et al. (2016). Expanding antigen-specific regulatory networks to treat autoimmunity. Nature., 530(7591), 434\u2013440. https:\/\/doi.org\/10.1038\/nature16962","journal-title":"Nature."},{"issue":"6","key":"10353_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","volume":"49","author":"MG Roncarolo","year":"2018","unstructured":"Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M., & Gagliani, N. (2018). The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity., 49(6), 1004\u20131019. https:\/\/doi.org\/10.1016\/j.immuni.2018.12.001","journal-title":"Immunity."},{"key":"10353_CR24","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3389\/fimmu.2018.02511","volume":"9","author":"A Butera","year":"2018","unstructured":"Butera, A., Sanchez, M., Pronio, A., Amendola, A., De Nitto, D., Di Carlo, N., et al. (2018). CD3+CD4+LAP+Foxp3-regulatory cells of the colonic Lamina Propria limit disease extension in ulcerative colitis. Frontiers in Immunology, 9, 2511. https:\/\/doi.org\/10.3389\/fimmu.2018.02511","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10353_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jaci.2017.12.984","volume":"142","author":"JS Alfen","year":"2018","unstructured":"Alfen, J. S., Larghi, P., Facciotti, F., Gagliani, N., Bosotti, R., Paroni, M., et al. (2018). Intestinal IFN-gamma-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. The Journal of Allergy and Clinical Immunology, 142(5), 1537\u20131547 e1538. https:\/\/doi.org\/10.1016\/j.jaci.2017.12.984","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"7","key":"10353_CR26","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., et al. (2017). Chemically induced mouse models of acute and chronic intestinal inflammation. Nature Protocols, 12(7), 1295\u20131309. https:\/\/doi.org\/10.1038\/nprot.2017.044","journal-title":"Nature Protocols"},{"issue":"1","key":"10353_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.gastro.2014.08.003","volume":"148","author":"BG Levesque","year":"2015","unstructured":"Levesque, B. G., Sandborn, W. J., Ruel, J., Feagan, B. G., Sands, B. E., & Colombel, J. F. (2015). Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology., 148(1), 37\u201351 e31. https:\/\/doi.org\/10.1053\/j.gastro.2014.08.003","journal-title":"Gastroenterology."},{"issue":"4","key":"10353_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5009\/gnl16308","volume":"11","author":"KH Katsanos","year":"2017","unstructured":"Katsanos, K. H., & Papadakis, K. A. (2017). Inflammatory bowel disease: Updates on molecular targets for biologics. Gut and Liver, 11(4), 455\u2013463. https:\/\/doi.org\/10.5009\/gnl16308","journal-title":"Gut and Liver"},{"issue":"1","key":"10353_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T., Siegmund, B., Le Berre, C., Wei, S. C., Ferrante, M., Shen, B., et al. (2020). Ulcerative colitis. Nature Reviews Disease Primers, 6(1), 74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x","journal-title":"Nature Reviews Disease Primers"},{"issue":"5","key":"10353_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","volume":"18","author":"D Garcia-Olmo","year":"2003","unstructured":"Garcia-Olmo, D., Garcia-Arranz, M., Garcia, L. G., Cuellar, E. S., Blanco, I. F., Prianes, L. A., et al. (2003). Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: A new cell-based therapy. International Journal of Colorectal Disease, 18(5), 451\u2013454. https:\/\/doi.org\/10.1007\/s00384-003-0490-3","journal-title":"International Journal of Colorectal Disease"},{"issue":"8","key":"10353_CR31","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1053\/j.gastro.2019.02.005","volume":"156","author":"A Dige","year":"2019","unstructured":"Dige, A., Hougaard, H. T., Agnholt, J., Pedersen, B. G., Tencerova, M., Kassem, M., et al. (2019). Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn's disease. Gastroenterology., 156(8), 2208\u20132216 e2201. https:\/\/doi.org\/10.1053\/j.gastro.2019.02.005","journal-title":"Gastroenterology."},{"issue":"8","key":"10353_CR32","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1053\/j.gastro.2019.01.032","volume":"156","author":"M Serrero","year":"2019","unstructured":"Serrero, M., Grimaud, F., Philandrianos, C., Visee, C., Sabatier, F., & Grimaud, J. C. (2019). Long-term safety and efficacy of local microinjection combining autologous microfat and adipose-derived stromal vascular fraction for the treatment of refractory perianal fistula in Crohn's disease. Gastroenterology., 156(8), 2335\u20132337 e2332. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.032","journal-title":"Gastroenterology."},{"issue":"1","key":"10353_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjz116","volume":"14","author":"MC Barnhoorn","year":"2020","unstructured":"Barnhoorn, M. C., Wasser, M., Roelofs, H., Maljaars, P. W. J., Molendijk, I., Bonsing, B. A., et al. (2020). Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn's disease perianal fistulas. Journal of Crohn's & Colitis, 14(1), 64\u201370. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz116","journal-title":"Journal of Crohn's & Colitis"},{"issue":"5","key":"10353_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ibd\/izz215","volume":"26","author":"AL Lightner","year":"2020","unstructured":"Lightner, A. L., Dozois, E. J., Dietz, A. B., Fletcher, J. G., Friton, J., Butler, G., et al. (2020). Matrix-delivered autologous mesenchymal stem cell therapy for refractory rectovaginal Crohn's fistulas. Inflammatory Bowel Diseases, 26(5), 670\u2013677. https:\/\/doi.org\/10.1093\/ibd\/izz215","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10353_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-020-01636-4","volume":"11","author":"C Zhou","year":"2020","unstructured":"Zhou, C., Li, M., Zhang, Y., Ni, M., Wang, Y., Xu, D., et al. (2020). Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: An open-label, controlled trial. Stem Cell Research & Therapy, 11(1), 124. https:\/\/doi.org\/10.1186\/s13287-020-01636-4","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10353_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/codi.15324","volume":"23","author":"M Nikolic","year":"2021","unstructured":"Nikolic, M., Stift, A., Reinisch, W., Vogelsang, H., Matic, A., Muller, C., et al. (2021). Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease. Colorectal Disease, 23(1), 153\u2013158. https:\/\/doi.org\/10.1111\/codi.15324","journal-title":"Colorectal Disease"},{"issue":"5","key":"10353_CR37","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Panes","year":"2018","unstructured":"Panes, J., Garcia-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., et al. (2018). Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease. Gastroenterology., 154(5), 1334\u20131342 e1334. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.020","journal-title":"Gastroenterology."},{"issue":"1","key":"10353_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","volume":"153","author":"AB Dietz","year":"2017","unstructured":"Dietz, A. B., Dozois, E. J., Fletcher, J. G., Butler, G. W., Radel, D., Lightner, A. L., et al. (2017). Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease. Gastroenterology., 153(1), 59\u201362 e52. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.001","journal-title":"Gastroenterology."},{"issue":"1","key":"10353_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.gastro.2015.03.013","volume":"149","author":"E Sala","year":"2015","unstructured":"Sala, E., Genua, M., Petti, L., Anselmo, A., Arena, V., Cibella, J., et al. (2015). Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine. Gastroenterology., 149(1), 163\u2013176 e120. https:\/\/doi.org\/10.1053\/j.gastro.2015.03.013","journal-title":"Gastroenterology."},{"issue":"8","key":"10353_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jcyt.2019.05.003","volume":"21","author":"R Ciccocioppo","year":"2019","unstructured":"Ciccocioppo, R., Baumgart, D. C., Dos Santos, C. C., Galipeau, J., Klersy, C., & Orlando, G. (2019). Perspectives of the International Society for Cell & gene therapy gastrointestinal scientific committee on the intravenous use of mesenchymal stromal cells in inflammatory bowel disease (PeMeGi). Cytotherapy., 21(8), 824\u2013839. https:\/\/doi.org\/10.1016\/j.jcyt.2019.05.003","journal-title":"Cytotherapy."},{"issue":"1","key":"10353_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/cells9010110","volume":"9","author":"I Tindemans","year":"2020","unstructured":"Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020). Dissecting the heterogeneity in T-cell mediated inflammation in IBD. Cells., 9(1), 110. https:\/\/doi.org\/10.3390\/cells9010110","journal-title":"Cells."},{"issue":"5","key":"10353_CR42","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/stem.3151","volume":"38","author":"N Negi","year":"2020","unstructured":"Negi, N., & Griffin, M. D. (2020). Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance. Stem Cells, 38(5), 596\u2013605. https:\/\/doi.org\/10.1002\/stem.3151","journal-title":"Stem Cells"},{"issue":"2","key":"10353_CR43","doi-asserted-by":"publisher","first-page":"e48052","DOI":"10.15252\/embr.201948052","volume":"21","author":"AC Court","year":"2020","unstructured":"Court, A. C., Le-Gatt, A., Luz-Crawford, P., Parra, E., Aliaga-Tobar, V., Batiz, L. F., et al. (2020). Mitochondrial transfer from MSCs to T cells induces Treg differentiation and restricts inflammatory response. EMBO Reports, 21(2), e48052. https:\/\/doi.org\/10.15252\/embr.201948052","journal-title":"EMBO Reports"},{"issue":"8","key":"10353_CR44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/stem.3185","volume":"38","author":"RI Azevedo","year":"2020","unstructured":"Azevedo, R. I., Minskaia, E., Fernandes-Platzgummer, A., Vieira, A. I. S., da Silva, C. L., Cabral, J. M. S., et al. (2020). Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro. Stem Cells, 38(8), 1007\u20131019. https:\/\/doi.org\/10.1002\/stem.3185","journal-title":"Stem Cells"},{"issue":"18","key":"10353_CR45","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos, D., Jitschin, R., Johansson, C. C., Okita, R., Kiessling, R., & Le Blanc, K. (2011). The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood., 117(18), 4826\u20134835. https:\/\/doi.org\/10.1182\/blood-2010-12-324038","journal-title":"Blood."},{"key":"10353_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fimmu.2017.00462","volume":"8","author":"P Mancheno-Corvo","year":"2017","unstructured":"Mancheno-Corvo, P., Lopez-Santalla, M., Menta, R., DelaRosa, O., Mulero, F., Del Rio, B., et al. (2017). Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the severity of collagen-induced experimental arthritis. Frontiers in Immunology, 8, 462. https:\/\/doi.org\/10.3389\/fimmu.2017.00462","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10353_CR47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonzalez","year":"2009","unstructured":"Gonzalez, M. A., Gonzalez-Rey, E., Rico, L., Buscher, D., & Delgado, M. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology., 136(3), 978\u2013989. https:\/\/doi.org\/10.1053\/j.gastro.2008.11.041","journal-title":"Gastroenterology."},{"issue":"1","key":"10353_CR48","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12917-018-1684-9","volume":"14","author":"JH An","year":"2018","unstructured":"An, J. H., Song, W. J., Li, Q., Kim, S. M., Yang, J. I., Ryu, M. O., et al. (2018). Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice. BMC Veterinary Research, 14(1), 354. https:\/\/doi.org\/10.1186\/s12917-018-1684-9","journal-title":"BMC Veterinary Research"},{"key":"10353_CR49","doi-asserted-by":"publisher","first-page":"604021","DOI":"10.3389\/fcell.2020.604021","volume":"8","author":"Y Li","year":"2020","unstructured":"Li, Y., Ma, K., Zhang, L., Xu, H., & Zhang, N. (2020). Human umbilical cord blood derived-mesenchymal stem cells alleviate dextran sulfate sodium-induced colitis by increasing regulatory T cells in mice. Frontiers in Cell and Development Biology, 8, 604021. https:\/\/doi.org\/10.3389\/fcell.2020.604021","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"1","key":"10353_CR50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-021-00688-z","volume":"6","author":"X He","year":"2021","unstructured":"He, X., Hong, W., Yang, J., Lei, H., Lu, T., He, C., et al. (2021). Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Signal Transduction and Targeted Therapy, 6(1), 270. https:\/\/doi.org\/10.1038\/s41392-021-00688-z","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10353_CR51","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/eji.201747316","volume":"48","author":"T Jofra","year":"2018","unstructured":"Jofra, T., Di Fonte, R., Galvani, G., Kuka, M., Iannacone, M., Battaglia, M., et al. (2018). Tr1 cell immunotherapy promotes transplant tolerance via de novo Tr1 cell induction in mice and is safe and effective during acute viral infection. European Journal of Immunology, 48(8), 1389\u20131399. https:\/\/doi.org\/10.1002\/eji.201747316","journal-title":"European Journal of Immunology"},{"issue":"14","key":"10353_CR52","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.3390\/ijms22147618","volume":"22","author":"A Saez","year":"2021","unstructured":"Saez, A., Gomez-Bris, R., Herrero-Fernandez, B., Mingorance, C., Rius, C., & Gonzalez-Granado, J. M. (2021). Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease. International Journal of Molecular Sciences, 22(14), 7618. https:\/\/doi.org\/10.3390\/ijms22147618","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-022-10353-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-022-10353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T13:33:14Z","timestamp":1663680794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-022-10353-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10353"],"URL":"https:\/\/doi.org\/10.1007\/s12015-022-10353-9","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"6 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Animal experiments were approved by the ethics committee of the First Hospital of Jilin Hospital, Changchun, China (approval number: 2021\u20130877).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}